• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 4.76% 11.0¢

NEUROTECH INTERNATIONAL LIMITED

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused on the development and commercialization of neurological solutions focused predominately on pediatric neurological disorders. The Company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its NTI/Dolce cannabis strains. It is also commercializing Mente, a home therapy to increase engagement and improve relaxation in autistic children with elevated delta-band brain activity. Its product, Mente Autism, assists with the management of children with autism spectrum disorder (ASD). Its development program NTI164 completed a Phase I/II clinical trial to treat patients with autism spectrum disorder (ASD). Mente Autism is a portable, electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to helo-relax the minds of children with ASD. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI
Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD
28/03/24 2 254
28/03/24 Last post  Symxpnotic98 Comments Created with Sketch.  2  Views Created with Sketch.  254 
NTI
Chart - NTI
2 3
28/03/24 132 46K
28/03/24 Last post  Tony barber Comments Created with Sketch.  132  Views Created with Sketch.  46K 
NTI
[INTERVIEW] Brian Leedman’s BlinkLab to join ASX
28/03/24 0 71
TRENDING NEWS

Diversification and low trading fees: Is this the ‘secret sauce’ to saving your investment portfolio?

NEWS
28 Mar 2024
28/03/24 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  71 
NTI 27/03/24 0 200
27/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  200 
NTI 22/03/24 6 1.6K
22/03/24 Last post  mj873 Comments Created with Sketch.  6  Views Created with Sketch.  1.6K 
NTI 21/03/24 0 206
21/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  206 
NTI
Just Cheap-- real cheap
21/03/24 42 23K
21/03/24 Last post  mj873 Comments Created with Sketch.  42  Views Created with Sketch.  23K 
NTI
Significant Re Rating $80 to $800m
20/03/24 20 8.4K
20/03/24 Last post  glory Comments Created with Sketch.  20  Views Created with Sketch.  8.4K 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
27 Mar 17:51
 
Appointment of Joint Company Secretary
21 Mar 16:10
 
Neurotech Presentation at NWR Virtual Healthcare Conference
21 Mar 08:49
 
Neurotech to present at NWR Virtual Healthcare Conference
19 Mar 11:49
 
Secondary Trading Notice
15 Mar 19:41
 
Notification regarding unquoted securities - NTI
15 Mar 18:41
 
View More arrow Created with Sketch.
(20min delay)
Last
11.0¢
Change
0.005(4.76%)
Mkt cap ! $100.9M
Open High Low Value Volume
10.5¢ 11.0¢ 10.3¢ $181.1K 1.695M

Buyers (Bids)

No. Vol. Price($)
4 200400 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 122053 4
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
10.5¢
  Change
0.005 ( 6.06 %)
Open High Low Volume
10.3¢ 11.0¢ 10.0¢ 611824
Last updated 15.56pm 28/03/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.